Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.60 – $3.13
40% from low
No one on the platform currently holds CHEK.
No tracked institution reports a position in CHEK as of their last filing.
| Execution date | Ratio |
|---|---|
| 2022-11-25 | 1-for-20reverse |
| 2018-04-04 | 1-for-12reverse |
No one on the platform has traded CHEK yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $76M | +3205.8% | $-2.14 | $-2.14–$-2.14 | — | 1 |
| 2027 | $99M | +29.4% | $6.14 | $6.14–$6.14 | 0.3× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| CHEKCheck-Cap Ltd. | $1.86 | +1.64% | $11M | — |
| ACXPAcurx Pharmaceuticals, Inc. | $1.48 | -3.90% | $6M | — |
| ADILAdial Pharmaceuticals, Inc. | $4.39 | +1.86% | $4M | — |
| BFRIBiofrontera Inc. | $1.26 | +0.80% | $16M | — |
| GBSGBS Inc. | $0.47 | -1.58% | $433577 | — |
| HCWBHCW Biologics Inc. | $2.92 | -7.00% | $1M | — |
| LUCYLucyd, Inc | $0.75 | +4.03% | $5M | — |
Source: Financial Modeling Prep · peers by sector/industry